TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
10x Genomics Sweden AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
267,546
|
256,284
|
159,178 |
Financial expenses |
312
|
8
|
12 |
Earnings before taxes |
153,832
|
135,830
|
75,387 |
EBITDA |
163,387
|
145,361
|
78,185 |
Total assets |
370,232
|
260,403
|
135,638 |
Current assets |
351,191
|
232,185
|
108,511 |
Current liabilities |
35,247
|
56,206
|
39,174 |
Equity capital |
334,985
|
204,197
|
96,464 |
- share capital |
50
![]() |
50
![]() |
50 |
Employees (average) |
39
|
45
|
38 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
90.5%
|
78.4%
|
71.1% |
Turnover per employee |
6,860
|
5,695
|
4,189 |
Profit as a percentage of turnover |
57.5%
|
53.0%
|
47.4% |
Return on assets (ROA) |
41.6%
|
52.2%
|
55.6% |
Current ratio |
996.4%
|
413.1%
|
277.0% |
Return on equity (ROE) |
45.9%
|
66.5%
|
78.2% |
Change turnover |
11,262
|
97,106
|
81,570 |
Change turnover % |
4%
|
61%
|
105% |
Chg. No. of employees |
-6
|
7
|
18 |
Chg. No. of employees % |
-13%
|
18%
|
90% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.